Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Journal of Immunological Methods|January 1, 1981
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometryP H De Mulder, J M Wessels, D A Rosenbrand, et al.
The Netherlands Journal of Medicine|January 1, 1980
Selection of lymphocytes spontaneously transformed in vivo by means of density centrifugationB E De Pauw, P H De Mulder, E J Geestman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanismR C Van Schie, R G Verstraten, J G Van de Winkel, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activityL T Balemans, V Mattijssen, P A Steerenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemiaP M Netten, P H de Mulder, A G Theeuwes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumorsC N Sternberg, P H de Mulder, A T van Oosterom, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
Reduction of therapeutic efficacy by a second cycle of PEG-IL-2P A Steerenberg, L T Balemans, B H Kremer, et al.
British Journal of Cancer|January 1, 1997
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II studyC J Punt, C M van Herpen, R L Jansen, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesV Mattijssen, P H De Mulder, L Schalkwijk, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|November 1, 1992
Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I studyK C Punt, R L Jansen, P H De Mulder, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Journal of Immunological Methods|January 1, 1981
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometryP H De Mulder, J M Wessels, D A Rosenbrand, et al.
The Netherlands Journal of Medicine|January 1, 1980
Selection of lymphocytes spontaneously transformed in vivo by means of density centrifugationB E De Pauw, P H De Mulder, E J Geestman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanismR C Van Schie, R G Verstraten, J G Van de Winkel, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activityL T Balemans, V Mattijssen, P A Steerenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemiaP M Netten, P H de Mulder, A G Theeuwes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumorsC N Sternberg, P H de Mulder, A T van Oosterom, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
Reduction of therapeutic efficacy by a second cycle of PEG-IL-2P A Steerenberg, L T Balemans, B H Kremer, et al.
British Journal of Cancer|January 1, 1997
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II studyC J Punt, C M van Herpen, R L Jansen, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesV Mattijssen, P H De Mulder, L Schalkwijk, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|November 1, 1992
Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I studyK C Punt, R L Jansen, P H De Mulder, et al.
Pageof 14